Incyte Corporation (NASDAQ:INCY) Financial Overview and Stock Analysis

Core Viewpoint - Incyte Corporation is experiencing strong financial performance driven by its flagship product, Jakafi, despite a price target set by RBC Capital indicating potential downside for the stock [2][5]. Financial Performance - Incyte reported earnings of $2.26 per share for Q3 2025, surpassing the Zacks Consensus Estimate of $1.66 per share, resulting in an earnings surprise of 36.14% [2]. - The company's revenue for Q3 2025 was $1.37 billion, exceeding the Zacks Consensus Estimate by 8.71% and increasing from $1.14 billion in the same period last year [3]. - Incyte has consistently outperformed revenue expectations over the past four quarters, with strong demand for Jakafi being a key growth driver [3]. Stock Performance - The current stock price for Incyte is $89.66, reflecting a decrease of 2.17% with a trading range between $88.34 and $94.42 for the day [4]. - Over the past year, the stock has reached a high of $94.42 and a low of $53.56, with a market capitalization of approximately $17.5 billion [4][5]. - RBC Capital has set a price target of $84 for Incyte, suggesting a potential downside of approximately -8.35% from the current trading price [2].